SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Street Walker who wrote (11)1/28/1999 1:25:00 PM
From: StockMiser  Read Replies (1) of 5582
 
SW - that's a great point. Allen Gunn's 12 month target is $24 NOT counting the Zicam product, which could easily outsell all of Gumtech's products combined.

That certainly reduces risk here. If GUMM never sold a single package of Zicam, it's still at 1/2 the price target.

Also very nice knowing that the product is fully developed (not some vaporware hype), and is actually already in test markets.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News